Author

R. Martinelli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:mouse· 2 Research Focus:database / resource· 1 Approach:deep learning· 1

Frequent Co-Authors

A. D. Werts· 1 shared A. G. Therien· 1 shared A. M. Healy· 1 shared A. R. Charbit· 1 shared A. R. Pandiri· 1 shared B. M. Gruner· 1 shared B. Shyong· 1 shared C. A. Powell· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. D. Werts

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Lung Cancer Mouse Model Database

L. Cai, Y. Gao, R. J. DeBerardinis, G. Acquaah-Mensah, V. Aidinis, J. E. Beane, S. Biswal, T. Chen, C. P. Concepcion-Crisol, B. M. Gruner, D. Jia, R. Jones, J. M. Kurie, M. G. Lee, P. Lindahl, , J. D. Minna

The paper establishes a database of lung cancer mouse models to improve data comparison and translational relevance by aligning mouse mutations with human lung cancer mutations.

bioRxiv · Feb 28, 2024 · PreprintCancer Biology

Novel neutrophil subsets associated with sepsis, vascular dysfunction and metabolic alterations identified using systems immunology

R. Martinelli, U. Parthasarathy, Y. Kuang, G. Thakur, J. D. Hogan, T. P. Wyche, J. E. Norton, J. R. Killough, T. R. Sana, C. Beakes, B. Shyong, R. N. Zhang, D. A. Gutierrez, M. Filbin, D. C. Christiani, , C. H. White

The paper identifies novel neutrophil subsets in sepsis patients using systems immunology and links them to cytokines, metabolites, and lipids, enabling a predictive model for patient classification.

bioRxiv · Feb 1, 2022 · PreprintImmunology

Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE-2 in vitro

K. Khanna, W. Raymond, J. Jin, A. R. Charbit, I. Gitlin, M. Tang, A. D. Werts, E. G. Barrett, J. M. Cox, S. M. Birch, R. Martinelli, H. S. Sperber, S. Franz, S. Pillai, A. M. Healy, , J. V. Fahy

Thiol drugs inhibit SARS-CoV-2 infection in vitro and reduce lung injury in vivo, supporting their potential as COVID-19 treatments.

bioRxiv · Dec 8, 2020 · PreprintMicrobiology